Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan

Imamura T; Yokosuka O; Kurihara T; Kanda T; Fukai K; Imazeki F; Saisho H
November 2003
Gut;Nov2003, Vol. 52 Issue 11, p1630
Academic Journal
BACKGROUND: Although it has been reported that different hepatitis B virus (HBV) genotypes induce different clinical characteristics in patients with chronic liver diseases (CLD), there have been few reports that have detailed the distribution of HBV genotypes in acute forms of liver disease. METHODS: HBV genotypes were determined in 61 patients who had acute forms of liver disease (45 had acute self limited hepatitis (AH) and 16 had fulminant hepatitis (FH)) and in 531 patients with CLD, including 19 patients with severe acute exacerbation of CLD. We also analysed the enhancer II, core promoter, and precore region sequences for the presence of mutations. RESULTS: Expression of genotype B in patients with acute forms of liver disease was significantly greater than in those with CLD (39.3% v 11.7%, respectively; p<0.001). Furthermore, expression of genotype B was significantly greater in patients with FH than in those with AH (62.5% v 31.1%, respectively; p=0.027). The precore mutation A1896 and the core promoter mutation at nt 1753 and 1754 were found more frequently in FH than in AH, and genotype B was predominant in FH regardless of the presence of these mutations. CONCLUSIONS: HBV genotype B was found more frequently in patients with acute forms of liver disease than in patients with CLD, and more frequently in patients with FH than in those with AH. These results suggest that this HBV genotype may induce more severe liver damage than other viral genotypes, at least in patients from Chiba, Japan.


Related Articles

  • Hepatitis B Virus-related Liver Disease Burden in South Asia. Chowdhury, Abhijit // Euroasian Journal of Hepato-Gastroenterology;Jul-Dec2011, Vol. 1 Issue 2, p44 

    Hepatitis B is major health concern globally, specially in the Asia-Pacific region. The virus results in countless premature mortalities and greater number of morbidities. While the scientific community is more focused toward HBV-related liver disease burden, the toll of this virus on our...

  • Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea. Hyung Yim; Yun Chang; Yeon Suh; Jong Yeon; Chang Lee; Jung Kwon; Wangdon Yoo; Soo-Ok Kim; Sun Hong // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2403 

    Abstract  The levels of HBV replication in the nonreplicative phase are not clear. We conducted this study to evaluate the levels of viral replication during the nonreplicative phase in chronic HBV-infected Korean patients using real-time PCR. A total of 125 patients were...

  • Frequency and Clinical Profile of Precore and Surface Hepatitis B Mutants in Asian-Indian Patients with Chronic Liver Disease. Guptan, R. C.; Thakur, V.; Sarin, S. K.; Banerjee, K.; Khandekar, P. // American Journal of Gastroenterology;Jul1996, Vol. 91 Issue 7, p1312 

    Background: Infection due to hepatitis B virus (HBV) could be due to wild or mutant (precore or surface) viruses. The prevalence and clinical profile of different viral forms in patients with chronic liver disease has not been established. Methods: One hundred and twenty patients with...

  • The changing prevalence of hepatitis B virus infection among men who have sex with men who attended a sexually transmitted infections clinic in Edinburgh, Scotland between 1989 and 2003. McMillan, Alexander // International Journal of STD & AIDS;Aug2006, Vol. 17 Issue 8, p539 

    The aim of the study was to discover if the prevalence of serological markers of hepatitis B virus infection among men who have sex with men (MSM) who attended a sexually transmitted infections clinic in Edinburgh, Scotland had changed in a 15-year period. This was a retrospective study of 3334...

  • Hepatitis C Virus Infection May Lead to Slower Emergence of P. falciparum in Blood. Ouwe-Missi-Oukem-Boyer, Odile; TouréNdouo, Fousseyni S.; Ollomo, Benjamin; Mezui-Me-Ndong, Jérome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; akuwa, Maria; Roques, Pierre; Branger, Michel; Preux, Pierre-Marie; Mazier, Dominique; Bisser, Sylvie // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: Areas endemic for Plasmodium falciparum, hepatitis B virus (HBV) and hepatitis C virus (HCV) overlap in many parts of sub-Saharan Africa. HBV and HCV infections develop in the liver, where takes place the first development stage of P. falciparum before its further spread in blood....

  • Antiviral Therapy for Chronic Hepatitis B: A Review. Hanazaki, Kazuhiro // Current Drug Targets - Inflammation & Allergy;Mar2004, Vol. 3 Issue 1, p63 

    Chronic hepatitis B virus (HBV) infection is a well-recognized risk factor for the development of hepatocellular carcinoma (HCC), which is becoming a more prevalent clinical problem, especially in HBV-endemic areas. It is estimated that 1.25 million people in the United States and more than 300...

  • GB Virus-C/Hepatitis G Virus Infection in Taiwan: A Virus That Fails to Cause a Disease? Jia-Horng Kao; Ding-Shinn Chen // Journal of Biomedical Science;1999, Vol. 6 Issue 4, p220 

    Recently, an RNA virus designated GB virus-C or hepatitis G virus (GBV-C/HGV) was identified; however, its clinical significance remains uncertain. This discovery prompted us to investigate the virological, epidemiological and clinical implications of GBV-C/HGV infection in Taiwan where chronic...

  • Chinese Herbal Medicine and Interferon in the Treatment of Chronic Hepatitis B: A Meta-Analysis of Randomized, Controlled Trials. McCulloch, Michael; Broffman, Michael; Jin Gao; Cofford, John M. // American Journal of Public Health;Oct2002, Vol. 92 Issue 10, p1619 

    Objectives. This meta-analysis was conducted to examine the effectiveness of Chinese herbal medicine (either alone or with interferon alfa) in treating chronic hepatitis B. Methods. We searched the TCMLARS, AMED, CISCOM, EMBASE, MEDLINE, and Cochrane Collaboration databases and then...

  • NIRF, a novel ubiquitin ligase, interacts with hepatitis B virus core protein and promotes its degradation. Qian, Guanhua; Jin, Fangmin; Chang, Lei; Yang, Yan; Peng, Huimin; Duan, Changzhu // Biotechnology Letters;Jan2012, Vol. 34 Issue 1, p29 

    Hepatitis B virus (HBV) core protein (HBc) is a major component of viral nucleocapsid and a multifunctional protein involved in viral maturation and release. It is unstable and present in cells at low level because of K96 lysine residue, which is a ubiquitin acceptor site. Np95/ICBP90-like RING...


Read the Article


Sign out of this library

Other Topics